Evaluation of Academic Performance in Asian Children Aged 8 to 11 Years With Attention-Deficit/Hyperactivity Disorder Treated With Atomoxetine Hydrochloride

Eli Lilly and Company0 个研究点开始时间: 2021年12月2日最近更新: 2021年12月6日

适应症

试验速览

暂无简介。

•Male or female outpatients between 8 and 11 years of age at study entry
•Attention-Deficit/Hyperactivity Disorder (ADHD) meeting the Diagnostic and Statistical Manual of Mental Disorders Fourth Edition, Text Revision (DSM-IV-TR) disease diagnostic criteria
•Patients who have never received medications psychotropic medications specifically to treat ADHD, or if they have received medication, that the trial of the psychotropic medication(s) was of less than 1 month duration, and occurred more than 6 months prior to study entry
•Normal intelligence in the judgment of the investigator
•Must be able to swallow capsules
•Are the trial subjects under 18? yes
•Number of subjects for this age range: 228
•F.1.2 Adults (18-64 years) no
•F.1.2.1 Number of subjects for this age range
•F.1.3 Elderly (>=65 years) no
•F.1.3.1 Number of subjects for this age range

•Current or past history of bipolar I or II disorder, psychosis, autism, Asperger's syndrome, pervasive developmental disorder, or conduct disorder
•History of seizure disorder or currently taking anticonvulsants for seizure control
•Serious suicidal risk as determined by investigator
•Cardiovascular disease; current or past history of hypertension
•Previous treatment with atomoxetine

发起方